Skip to content

Dimitri de Bundel

Vrije Universiteit Brussel

2 papers in the library · 11 citations · publishing 2022-2025

Papers

Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice

International Journal of Molecular Sciences December 4, 2022 Mireia Medrano, An Buckinx, Ilse Smolders et al. 11 citations

Serotoninergic psychedelics like psilocybin can produce lasting reductions in depressive symptoms, but their mechanism is unclear. In a mouse forced swim test model, the psychedelic DOI was tested for effects on behavior and 5-HT2A receptor levels in the medial prefrontal cortex. Mice exposed to swim stress developed passive coping behavior six days later, but this was not linked to increased head twitch responses or consistent changes in 5-HT2A receptor levels. A low dose of DOI (0.2 mg/kg) unexpectedly increased immobility, while a high dose (2 mg/kg) had no significant effect. DOI did cause a dose-dependent decrease in 5-HT2A levels in stressed mice. These results do not support the idea that downregulating 5-HT2A receptors in the medial prefrontal cortex underlies antidepressant-like effects of serotoninergic psychedelics.

Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators

bioRxiv Preprint Server March 27, 2025 Jordy Peeters, Dimitri de Bundel, Kenno Vanommeslaeghe preprint

Activating the serotonin-2A receptor can produce antidepressant effects, but also risks hallucinations. Recent work suggests that using weak partial agonists or very low doses might separate these effects. Computer simulations of the receptor bound to different drugs show that modest activation may yield only antidepressant benefits, while excessive activation causes hallucinations. This finding points to a possible drug development strategy: administering a sufficiently weak partial agonist could provide therapeutic effects without hallucinogenic side effects, avoiding the abuse and narrow dosing problems of microdosing.